Senores (SENORES) | Stock Overview & Key Data

Senores Pharmaceuticals Ltd. | Small-cap | Healthcare

₹654.90

-2.20%

Senores vs GlaxoSmithKline Senores vs Pfizer Senores vs Sms Pharmaceuticals Senores vs TTK Healthcare Senores vs NGL Fine-Chem Senores vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Senores Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Senores	Healthcare Sector	NIFTY 50
1 Week	-3.10%	N/A	N/A
1 Month	16.33%	N/A	N/A
3 Months	34.83%	N/A	N/A
6 Months	13.40%	N/A	N/A
1 Year	12.90%	N/A	N/A
3 Years	12.90%	N/A	N/A
5 Years	12.90%	N/A	N/A

Stock Range

Today's Range

Low: ₹650.00 High: ₹669.90

on August 8, 2025

52 Week Range

Low: ₹435.25 High: ₹719.00

on January 13, 2025

on July 30, 2025

All-Time High: ₹719.00 on July 30, 2025

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR31.6B

EPS i 14.64

P/E Ratio (TTM) i 46.89

Forward P/E i 17.49

P/B Ratio i 4.09

PEG Ratio i 0.34

Div. Yield i N/A

ROE i 7.21%

Beta i N/A

Debt to Equity i 38.75

Financial Highlights

Profitability

Gross Margin i 52.91%

Operating Margin i 20.42%

Profit Margin i 14.82%

Returns and Earnings

Return on Assets (TTM) i 4.77%

Return on Equity (TTM) i 7.21%

EBITDA i INR1.2B

Net Income (TTM) i INR675.6M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR98.98

Quarterly Revenue Growth (YoY) i 71.70%

Quarterly Earnings Growth (YoY) i 83.90%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Senores SENORES	31.62B Small-cap	-3.10%	16.33%	34.83%	13.40%	16.85%	12.90%	12.90%	12.90%
GlaxoSmithKline GLAXO	479.22B Large-cap	-15.34%	-18.49%	-6.07%	21.26%	19.95%	-6.38%	85.69%	76.49%
Pfizer PFIZER	232.88B Large-cap	-3.36%	-13.98%	17.41%	15.19%	-5.42%	-13.67%	19.64%	12.63%
Sms Pharmaceuticals SMSPHARMA	19.63B Small-cap	-8.25%	-11.33%	-10.26%	-1.15%	-16.25%	-24.36%	146.65%	126.13%
TTK Healthcare TTKHLTCARE	16.62B Small-cap	-8.97%	-14.85%	-5.18%	-11.54%	-19.42%	-29.40%	36.00%	119.93%
NGL Fine-Chem NGLFINE	7.87B Small-cap	-6.46%	-0.05%	9.77%	-34.85%	-31.78%	-51.45%	-21.62%	-34.60%

Ownership & Short Interest

Insider Ownership i 56.12%

Institutional Ownership i 6.21%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 2M

Average 90-Day Volume i 720K

Senores Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Senores would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of Senores, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -3.10%
1 Month: 16.33%
3 Months: 34.83%
1 Year: 12.90%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is SENORES's 52-week high and low?

In the last 52 weeks, Senores reached a high of ₹719.00 (on July 30, 2025) and a low of ₹435.25 (on January 13, 2025).

What is the market cap and P/E ratio for SENORES?

Curious about Senores's size and valuation? Its market capitalization stands at 31.62B. When it comes to valuation, the P/E ratio (trailing twelve months) is 46.89, and the forward P/E (looking ahead) is 17.49.

Does SENORES pay dividends? If so, what's the yield?

As for dividends, Senores isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Senores's main competitors or similar companies to consider before investing?

When looking at Senores, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
GlaxoSmithKline GLAXO	479.22B	Healthcare	Drug Manufacturers - General	-6.38%	85.69%
Pfizer PFIZER	232.88B	Healthcare	Drug Manufacturers - General	-13.67%	19.64%
Sms Pharmaceuticals SMSPHARMA	19.63B	Healthcare	Drug Manufacturers - General	-24.36%	146.65%
TTK Healthcare TTKHLTCARE	16.62B	Healthcare	Drug Manufacturers - General	-29.40%	36.00%
NGL Fine-Chem NGLFINE	7.87B	Healthcare	Drug Manufacturers - General	-51.45%	-21.62%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Senores Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Senores's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.21%, the Debt to Equity ratio from the most recent quarter is 38.75, and its Gross Profit Margin stands at 52.91%.

What is the recent revenue and earnings growth for SENORES?

Looking at Senores's growth, its revenue over the trailing twelve months (TTM) was INR5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 71.70%, and quarterly earnings saw a YoY growth of 83.90%.

How much of SENORES stock is held by insiders and institutions?

Wondering who owns Senores stock? Company insiders (like executives and directors) hold about 56.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 6.21%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.